Lysophosphatidic Acid Receptor 1 (EDG2)
Product Specifications
Background
Endothelial cell differentiation gene-2 (EDG-2) receptor is a high affinity receptor for lysophosphatidic acid (LPA). EDG-2, also known as lysophospholipid receptor A1, Vzg-1, mrec1.3 or GPCR26, like all other EDG receptors, couple multiple (3 or more) types of G proteins and transduce decreases in c[AMP]i through Gi and increases in [Ca2+]i by augmenting phospholipase C through Gq/11 and beta/gamma dimers and by induction of PI3 kinase, p125 FAK, phospholipase D by activating rho through G12/13. Human EDG-2 is present in high levels on oligodendrocytes and certain Human malignant T cell lines. EDG-2 receptors (with EDG-4) may play a role in protecting cardiomyocytes from apoptosis induced by hypoxia and andrenergic stimulation.
Synonyms
EDG-2 transfected Cell lysate
UniProt
Q92633
Conjugation
Unconjugated
Type
Control Lysate
Applications
WB
Field of Research
Ancillary Reagents
Assay Principle
For use as a positive control with Exalpha's EDG2 (LPA1) polyclonal antibody (Cat. No. C174P) for Western blot analysis.
Stability
See expiration date on vial
Concentration
See vial for Concentration
Form
Provided in 10% glycerol, 0,063 M Tris-HCl (pH 6,8), 2% SDS and 0,002% bromophenol blue, 5% 2-mercaptoethanol
Precautions
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.
Shipping Conditions
Ambient Temperature, freeze upon arrival
Storage Conditions
Product should be stored at -20ºC; Aliquot to avoid freeze/thaw cycles
Functional Analysis
WB
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items